A detailed history of Gkv Capital Management Co., Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Gkv Capital Management Co., Inc. holds 119 shares of GH stock, worth $5,241. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119
Holding current value
$5,241
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$31.77 - $49.94 $3,780 - $5,942
119 New
119 $5.07 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.5B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Gkv Capital Management Co., Inc. Portfolio

Follow Gkv Capital Management Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gkv Capital Management Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gkv Capital Management Co., Inc. with notifications on news.